Close Menu

The Washington Post's Christopher Weaver says that, "over the past two decades, venture capitalists helped make possible striking advances in health care, including robotic surgery, cancer vaccines, and genomics." But US healthcare spending is "forecasted to grow in an unaffordable way for the country," says John Doerr from Kleiner Perkins Caufield & Byers -- a situation making more VCs focus on supporting companies that could help cut those costs, according to Weaver.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.